Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults
Completed · Phase 2
Conditions studied: Gastroduodenal Ulcerations, Erosion
In brief
The purpose of this study is to determine the subchronic gastrointestinal (GI) safety of PL3100 versus Naproxen in normal healthy volunteers.
Key facts
- Study ID
- NCT01139190
- Run by
- PLx Pharma
- People needed
- 77
- Starts
- 2010-07-01
- Expected to finish
- 2010-12-01
- Last updated by the study team
- 2016-04-11
Who can join
Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.
Where it is running
- Dallas VA Medical Center — Dallas, Texas, United States
- Houston Center For Clinical Research — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.